Long non-coding RNA SLCO4A1-AS1 drives the progression of non-small-cell lung cancer by modulating miR-223-3p/IKKα/NF-κB signaling

References

• Zeng H, Chen W, Zheng R, Zhang S, Ji JS, Zou X, Xia C, Sun K, Yang Z, Li H, et al. 2018. Changing cancer survival in China during 2003-15: a pooled analysis of 17 population-based cancer registries. Lancet Global Health. 6:e555–e67. doi:10.1016/S2214-109X(18)30127-X.
   PubMed Web of Science ®Google Scholar
• Hoffman PC, Mauer AM, Vokes EE. 2000. Lung cancer. The Lancet. 355:479–485. doi:10.1016/S0140-6736(00)82038-3.
   PubMed Web of Science ®Google Scholar
• Herbst RS, Morgensztern D, Boshoff C. 2018. The biology and management of non-small cell lung cancer. Nature. 553:446–454. doi:10.1038/nature25183.
   PubMed Web of Science ®Google Scholar
• Pfeifer GP, Denissenko MF, Olivier M, Tretyakova N, Hecht SS, Hainaut P. 2002. Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers. Oncogene. 21:7435–7451. doi:10.1038/sj.onc.1205803.
   PubMed Web of Science ®Google Scholar
• Akhtar-Danesh N, Finley C. 2015. Temporal trends in the incidence and relative survival of non-small cell lung cancer in Canada: A population-based study. Lung Cancer (Amsterdam, Netherlands). 90:8–14. doi:10.1016/j.lungcan.2015.07.004.
   PubMed Web of Science ®Google Scholar
• Wang D, Dai J, Hou S, Qian Y. 2019. LncRNA SNHG20 predicts a poor prognosis and promotes cell progression in epithelial ovarian cancer. Biosci Rep. 39(4).
   Web of Science ®Google Scholar
• Liang H, Yu T, Han Y, Jiang H, Wang C, You T, Zhao X, Shan H, Yang R, Yang L, et al. 2018. LncRNA PTAR promotes EMT and invasion-metastasis in serous ovarian cancer by competitively binding miR-101-3p to regulate ZEB1 expression. Mol Cancer. 17:119. doi:10.1186/s12943-018-0870-5.
   PubMed Web of Science ®Google Scholar
• Wang W, Luo P, Guo W, Shi Y, Xu D, Zheng H, Jia L. 2018. LncRNA SNHG20 knockdown suppresses the osteosarcoma tumorigenesis through the mitochondrial apoptosis pathway by miR-139/RUNX2 axis. Biochem Biophys Res Commun. 503:1927–1933. doi:10.1016/j.bbrc.2018.07.137.
   PubMed Web of Science ®Google Scholar
• Yang X, Song JH, Cheng Y, Wu W, Bhagat T, Yu Y, Abraham JM, Ibrahim S, Ravich W, Roland BC, et al. 2014. Long non-coding RNA HNF1A-AS1 regulates proliferation and migration in oesophageal adenocarcinoma cells. Gut. 63:881–890. doi:10.1136/gutjnl-2013-305266.
   PubMed Web of Science ®Google Scholar
• Wang Z, Jin J. 2019. LncRNA SLCO4A1-AS1 promotes colorectal cancer cell proliferation by enhancing autophagy via miR-508-3p/PARD3 axis. Aging. 11(14):4876–4889.
   Google Scholar
• Yang Y, Wang F, Huang H, Zhang Y, Xie H, Men T. 2019. lncRNA SLCO4A1-AS1 promotes growth and invasion of bladder cancer through sponging miR-335-5p to upregulate OCT4. Onco Targets Ther. 12:1351–1358. doi:10.2147/OTT.S191740.
   PubMedGoogle Scholar
• Yu J, Han Z, Sun Z, Wang Y, Zheng M, Song C. 2018. LncRNA SLCO4A1-AS1 facilitates growth and metastasis of colorectal cancer through beta-catenin-dependent Wnt pathway. J Exp Clin Cancer Res: CR. 37:222. doi:10.1186/s13046-018-0896-y.
   PubMed Web of Science ®Google Scholar
• Rao S, Morales AA, Pearse DD. 2015. The Comparative Utility of Viromer RED and Lipofectamine for Transient Gene Introduction into Glial Cells. Biomed Res Int. 2015:458624. doi:10.1155/2015/458624.
   PubMed Web of Science ®Google Scholar
• Wang G, Zhang ZJ, Jian WG, Liu PH, Xue W, Wang TD, Meng YY, Yuan C, Li HM, Yu YP, et al. 2019. Novel long noncoding RNA OTUD6B-AS1 indicates poor prognosis and inhibits clear cell renal cell carcinoma proliferation via the Wnt/beta-catenin signaling pathway. Mol Cancer. 18:15. doi:10.1186/s12943-019-0942-1.
   PubMed Web of Science ®Google Scholar
• Zhu LF, Song LD, Xu Q, Zhan JF. 2019. Highly expressed long non-coding RNA FEZF1-AS1 promotes cells proliferation and metastasis through Notch signaling in prostate cancer. Eur Rev Med Pharmacol Sci. 23:5122–5132. doi:10.26355/eurrev_201906_18176.
   PubMedGoogle Scholar
• Wang RK, Shao XM, Yang JP, Yan HL, Shao Y. 2019. MicroRNA-145 inhibits proliferation and promotes apoptosis of HepG2 cells by targeting ROCK1 through the ROCK1/NF-kappaB signaling pathway. Eur Rev Med Pharmacol Sci. 23:2777–2785. doi:10.26355/eurrev_201904_17551.
   PubMedGoogle Scholar
• Lan X, Liu X. 2019. LncRNA SNHG1 functions as a ceRNA to antagonize the effect of miR-145a-5p on the down-regulation of NUAK1 in nasopharyngeal carcinoma cell. J Cell Mol Med. 23:2351–2361. doi:10.1111/jcmm.13497.
   PubMed Web of Science ®Google Scholar
• Chen Y, Shen Z, Zhi Y, Zhou H, Zhang K, Wang T, Feng B, Chen Y, Song H, Wang R, et al. 2018. Long non-coding RNA ROR promotes radioresistance in hepatocelluar carcinoma cells by acting as a ceRNA for microRNA-145 to regulate RAD18 expression. Arch Biochem Biophys. 645:117–125. doi:10.1016/j.abb.2018.03.018.
   PubMed Web of Science ®Google Scholar
• Chen Z, Chen X, Lei T, Gu Y, Gu J, Huang J, Lu B, Yuan L, Sun M, Wang Z. 2020. Integrative Analysis of NSCLC Identifies LINC01234 as an Oncogenic lncRNA that Interacts with HNRNPA2B1 and Regulates miR-106b Biogenesis. Mol Ther. 28(6):1479–1493.
   Google Scholar
• Xu X, Zhou X, Chen Z, Gao C, Zhao L, Cui Y. 2020. Silencing of lncRNA XIST inhibits non-small cell lung cancer growth and promotes chemosensitivity to cisplatin. Aging (Albany NY). 12:4711–4726. doi:10.18632/aging.102673.
   PubMedGoogle Scholar
• Wu C, Zhu X-T, Xia L, Wang L, Yu W, Guo Q, Zhao M, Lou J. 2020. High expression of long noncoding RNA PCNA-AS1 promotes non-small-cell lung cancer cell proliferation and oncogenic activity via upregulating CCND1. J Cancer. 11:1959–1967. doi:10.7150/jca.39087.
   PubMed Web of Science ®Google Scholar
• Liu X, Chen W, Liu Q, Dai J. 2019. Abietic acid suppresses non-small-cell lung cancer cell growth via blocking IKKbeta/NF-kappaB signaling. Onco Targets Ther. 12:4825–4837. doi:10.2147/OTT.S199161.
   PubMed Web of Science ®Google Scholar
• Ji DG, Guan LY, Luo X, Ma F, Yang B, Liu HY. 2018. Inhibition of MALAT1 sensitizes liver cancer cells to 5-flurouracil by regulating apoptosis through IKKalpha/NF-kappaB pathway. Biochem Biophys Res Commun. 501:33–40. doi:10.1016/j.bbrc.2018.04.116.
   PubMed Web of Science ®Google Scholar
• Ambros V. 2003. MicroRNA pathways in flies and worms: growth, death, fat, stress, and timing. Cell. 113:673–676. doi:10.1016/S0092-8674(03)00428-8.
   PubMed Web of Science ®Google Scholar
• Sun W, Lv J, Duan L, Lin R, Li Y, Li S, Fu C, Zhao L, Xin S. 2019. Long noncoding RNA H19 promotes vascular remodeling by sponging let-7a to upregulate the expression of cyclin D1. Biochem Biophys Res Commun. 508:1038–1042. doi:10.1016/j.bbrc.2018.11.185.
   PubMed Web of Science ®Google Scholar
• Huang Y, Ni R, Wang J, Liu Y. 2019. Knockdown of lncRNA DLX6-AS1 inhibits cell proliferation, migration and invasion while promotes apoptosis by downregulating PRR11 expression and upregulating miR-144 in non-small cell lung cancer. Biomed Pharmacother. 109:1851–1859. doi:10.1016/j.biopha.2018.09.151.
   PubMed Web of Science ®Google Scholar
• Zhang L, Wang L, Wang Y, Chen T, Liu R, Yang W, Liu Q, Tu K. 2019. LncRNA KTN1-AS1 promotes tumor growth of hepatocellular carcinoma by targeting miR-23c/ERBB2IP axis. Biomed Pharmacother. 109:1140–1147. doi:10.1016/j.biopha.2018.10.105.
   PubMed Web of Science ®Google Scholar